- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 7.95M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $59.19M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $59.15M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $22.81M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $31.56M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.91B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.93B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $2.09B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.1B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 7.84M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $1.12M |
| Capex restated | Q1 2025 · Mar 31, 2024 | $4.78M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $7.12M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $168.95M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $169.27M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.24 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.24 |
| Net Income | Q1 2025 · Mar 31, 2024 | $1.9M |